Original PaperCoronary heart disease risk assessment and characterization of coronary artery disease using coronary CT angiography: comparison of asymptomatic and symptomatic groups
Introduction
The initial approach to the management of individuals at risk for coronary heart disease (CHD) is careful assessment of the patient’s overall risk. Traditional risk assessment tools, such as the Framingham risk score or the National Cholesterol Education Program (NCEP) guidelines, have been widely used for the assessment of patient risk.1 However, there is growing evidence that these traditional risk assessment tools, based on risk factor analysis, have substantial limitations when used to guide individual therapy.2, 3, 4 For example, patients in the high-risk CHD group with limited or no plaque formation may be subjected to life-long drug therapy, whereas others with low‑risk CHD, but substantial plaque formation, might be undertreated or not treated at all.
Coronary computed tomography (CT) angiography (CCTA) is a very useful, non-invasive method for the diagnosis of coronary artery disease (CAD), because it has high diagnostic accuracy and provides direct visualization of plaques, an advantage over conventional coronary angiography.5, 6 However, the application of CCTA has been limited due to the associated radiation exposure.7 Thus, according to the appropriateness criteria for cardiac CT created by the American College of Cardiology Foundation (ACCF), CCTA is not recommended for asymptomatic individuals with low-to-moderate CHD risk. Even in those patients with high CHD risk, the appropriateness criteria for CCTA use are uncertain.8
The purpose of the present study was to evaluate the prevalence of CAD in accordance with traditional CHD risk assessment, as well as to assess plaque characteristics in asymptomatic and symptomatic patients. The usefulness of Framingham risk score for the prediction of CAD using receiver operating characteristics (ROC) analysis was also evaluated.
Section snippets
Study population
From January 2006 to July 2008, a total of 693 individuals underwent CCTA at our institution. Additionally, the patients’ medical records and CCTA were retrospectively reviewed. Three hundred and three patients were excluded using the following exclusion criteria: incomplete medical record required for the assessment of CHD risk, non-diagnostic image quality obtained from CCTA, presence of typical anginal chest pain, or a history of CHD. The final study population included 390 patients.
The
Clinical characteristics of study population
Clinical characteristics of the asymptomatic and symptomatic patients are shown in Table 1. The median Framingham 10-year risk of coronary events was 8% (IQR: 3–12%) for the asymptomatic group and 8% (3–14%) for the symptomatic group. The proportion of participants with low, moderate, and high CHD risk was 30.4, 55.1, and 14.5%, respectively, in the asymptomatic group, and 29.8, 35.7, and 34.5% in the symptomatic group. There was a significant difference between the two groups with regard to
Discussion
The present study investigated the prevalence of CAD in asymptomatic and symptomatic individuals according to NCEP CHD risk stratification. The results of the present study revealed a high prevalence of CAD in individuals with low and moderate-risk for CHD in both the asymptomatic and symptomatic groups. The NCEP/ATP III guidelines, which are currently used to identify high-risk individuals in need of stringent control for risk factors, are based on a traditional risk factor analysis.1 These
References (25)
- et al.
Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform?
J Am Coll Cardiol
(2003) - et al.
Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines
J Am Coll Cardiol
(2005) - et al.
Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease
J Am Coll Cardiol
(2006) - et al.
Quantification of coronary artery calcium using ultrafast computed tomography
J Am Coll Cardiol
(1990) - et al.
Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians
J Am Coll Cardiol
(2009) - et al.
Screening for cardiovascular risk in asymptomatic patients
J Am Coll Cardiol
(2010) - et al.
Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS participating investigators and staff
J Am Coll Cardiol
(1993) - et al.
Correlation of coronary calcification and angiographically documented stenoses in patients with suspected coronary artery disease: results of 1,764 patients
J Am Coll Cardiol
(2001) - et al.
Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals
J Am Coll Cardiol
(2008) - et al.
Multislice computed tomography in an asymptomatic high-risk population
Am J Cardiol
(2007)
Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
Circulation
Traditional clinical risk assessment tools do not accurately predict coronary atherosclerotic plaque burden: a CT angiography study
AJR Am J Roentgenol
Cited by (13)
ACR appropriateness criteria asymptomatic patient at risk for coronary artery disease
2014, Journal of the American College of RadiologyCitation Excerpt :It is not known, however, whether CCTA can be used as a prognostic tool, independent of CACS and clinical risk models, to stratify asymptomatic patients and predict future cardiac events. Several studies examined CAD in asymptomatic patients and reported a relatively high prevalence of occult atherosclerosis; this discovery could have a significant impact on therapeutic decision making and management [35-39]. One relatively large study of 1,000 asymptomatic patients reported using CCTA to evaluate the prevalence of occult CAD and its ability to predict future adverse coronary events [36].
Coronary calcium score correlates with estimate of total plaque burden
2013, International Journal of CardiologyEvaluation of framingham and systematic coronary risk evaluation scores by coronary computed tomographic angiography in asymptomatic adults
2013, American Journal of CardiologyCitation Excerpt :Nonetheless, owing to its novelty, disagreement exists regarding the efficacy of the test for the prediction of cardiovascular risk compared to the Framingham score and the SCORE. Some studies have reported that CCTA and the calculation of the CS adds nothing to the conventional risk score calculations and thus is not worthwhile in terms of cost effectiveness.11,12,26–28 Other studies have indicated that measuring artery calcification, using CCTA, can identify coronary atherosclerosis.17,29
Distribution of 10-year risk for coronary heart disease and eligibility for therapeutic approaches among Tehranian adults
2011, Public HealthCitation Excerpt :Since a reduction in low-density lipoprotein cholesterol (LDL-C) should be the primary target of therapy in ATP III, therapeutic criteria are defined for this purpose according to each individual’s risk. Although some studies have provided estimates of the distribution of risk for CHD in other populations,12–14 there were differences between the study populations, the definitions of variables and the additional variables included in the equations, and these could be responsible for the differences between coefficients across studies. Since no studies have been conducted to estimate the risk of CHD according to NCEP ATP III in a diverse Iranian population, this study was carried out to investigate the risk of developing CHD in Tehranian adults, and the distributions of the population needing therapeutic lifestyle changes (TLCs) and additional drug therapy using the NCEP ATP III.
Evaluation of coronary artery disease in patients with atypical chest pain based on exercise test
2017, Journal of Babol University of Medical SciencesCoronary artery calcium score and CT angiography in asymptomatic elderly patients with high pretest probability for coronary artery disease
2016, Japanese Journal of Radiology